Hypermethylation of the O6-methylguanine-DNA methyltransferase gene (MGMT) promoter has been observed in normal tissues from CRC patients [16–18] and favors transition mutations in P53 and KRAS, suggesting an association with the progression of CRC. The gene discussed is KRAS; the disease is colorectal carcinoma.